Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

FDA grants orphan drug designation to olinciguat for sickle cell disease

June 8, 2018

Biogen enters agreement to acquire stroke drug candidate from TMS

June 8, 2018

Merck & Co. synthesizes new FXIIa inhibitors

June 7, 2018

FDA grants priority review to Hemlibra sBLA

June 5, 2018

Transfusion reductions seen with stem cell gene therapy for beta-thalassemia

June 1, 2018

Astellas and FibroGen announce topline data from Japanese phase III study of roxadustat

June 1, 2018

Doptelet becomes available in the U.S. for the treatment of thrombocytopenia

June 1, 2018

FDA places clinical hold on IND for CTX-001 in sickle cell disease

May 31, 2018

Tavalisse becomes available in the U.S.

May 30, 2018

European designation decisions for BioCryst's BCX-7353 for HAE

May 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...